MedPath

Aseptic Meningoencephalitis in Slovenia

Conditions
Aseptic Meningitis
Interventions
Drug: symptomatic therapy
Other: questionnaire
Registration Number
NCT02328469
Lead Sponsor
University Medical Centre Ljubljana
Brief Summary

The main objective of this study is:

* to establish etiology of acute aseptic meningitis/meningoencephalitis in Slovenia

* to assess the clinical course and outcome of tick-borne encephalitis and Lyme neuroborreliosis

* to characterize the inflammatory proteins, gene polymorphisms, and transcriptome profiles in patients with tick-borne encephalitis and Lyme neuroborreliosis

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
800
Inclusion Criteria
  • clinical picture compatible with aseptic meningitis/meningoencephalitis
  • age 18 years or older
  • clear cerebrospinal fluid on macroscopic examination
  • cerebrospinal pleocytosis (> 5 x 106 white blood cells per liter)
Exclusion Criteria
  • younger than 18 years
  • pregnant women

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Arm && Interventions
GroupInterventionDescription
Lyme neuroborreliosisCeftriaxone or DoxycyclinePatients with acute aseptic meningitis in whom Lyme neuroborreliosis will be proven or suspected according to microbiological criteria. Patients will be treated with antibiotic therapy (ceftriaxone or doxycycline) and will be asked to complete a questionnaire.
unidentified aseptic meningitisquestionnairePatients with etiologically unidentified aseptic meningitis will be treated with symptomatic therapy and will be asked to complete a questionnaire.
unidentified aseptic meningitissymptomatic therapyPatients with etiologically unidentified aseptic meningitis will be treated with symptomatic therapy and will be asked to complete a questionnaire.
tick-borne encephalitisquestionnairePatient with aseptic meningitis in whom serological diagnosis of tick-borne encephalitis will be established. Patients will be treated with symptomatic therapy and will be asked to complete a questionnaire.
Lyme neuroborreliosissymptomatic therapyPatients with acute aseptic meningitis in whom Lyme neuroborreliosis will be proven or suspected according to microbiological criteria. Patients will be treated with antibiotic therapy (ceftriaxone or doxycycline) and will be asked to complete a questionnaire.
healthy controlssymptomatic therapyPatients will be asked to refer a spouse to serve as a control . If unmarried they will be asked to refer a family member or a friend of +/- 5 years to serve as a control.
tick-borne encephalitissymptomatic therapyPatient with aseptic meningitis in whom serological diagnosis of tick-borne encephalitis will be established. Patients will be treated with symptomatic therapy and will be asked to complete a questionnaire.
Lyme neuroborreliosisquestionnairePatients with acute aseptic meningitis in whom Lyme neuroborreliosis will be proven or suspected according to microbiological criteria. Patients will be treated with antibiotic therapy (ceftriaxone or doxycycline) and will be asked to complete a questionnaire.
healthy controlsquestionnairePatients will be asked to refer a spouse to serve as a control . If unmarried they will be asked to refer a family member or a friend of +/- 5 years to serve as a control.
identified aseptic meningitissymptomatic therapyPatients with microbiologically identified cause of acute aseptic meningitis/meningoencephalitis will receive symptomatic therapy. If the identified causative agent will be Herpes Simplex Virus or Varicella Zoster Virus, patients will be treated with acyclovir and will be asked to complete a questionnaire.
identified aseptic meningitisAcyclovirPatients with microbiologically identified cause of acute aseptic meningitis/meningoencephalitis will receive symptomatic therapy. If the identified causative agent will be Herpes Simplex Virus or Varicella Zoster Virus, patients will be treated with acyclovir and will be asked to complete a questionnaire.
identified aseptic meningitisquestionnairePatients with microbiologically identified cause of acute aseptic meningitis/meningoencephalitis will receive symptomatic therapy. If the identified causative agent will be Herpes Simplex Virus or Varicella Zoster Virus, patients will be treated with acyclovir and will be asked to complete a questionnaire.
Primary Outcome Measures
NameTimeMethod
Changes in selected clinical parameters in patients with acute aseptic meningitis/meningoencephalitisat enrollment and during 12 months follow-up

Selected clinical parameters (presence or absence of headache, nausea, vomiting, neurologic symptoms, maximal temperature, etc) in aseptic meningitis/meningoencephalitis patients at enrollment (at admission to hospital) and at follow-up visits: on day 7 or on day of discharge from hospital, on day 14, at 2, 6, and 12 months.

Changes in selected microbiologic parameters in patients with acute aseptic meningitis/meningoencephalitisat enrollment and during 12 months follow-up

Selected microbiologic parameters (anti Borrelia burgdorferi immunoglobulin M and G in serum and cerebrospinal fluid results, polymerase chain reaction for enteroviruses, herpes simplex virus type 1 and 2 in cerebrospinal fluid results) in aseptic meningitis/meningoencephalitis patients at enrollment (at admission to hospital) and anti Borrelia burgdorferi immunoglobulin M and G in serum at follow-up visits: at 2, 6, and 12 months.

Changes in selected laboratory parameters in patients with acute aseptic meningitis/meningoencephalitisat enrollment and during 12 months follow-up

Selected laboratory parameters (complete blood count, biochemistry test results) in aseptic meningitis/meningoencephalitis patients at enrollment (at admission to hospital) and at follow-up visits: on day 7 or on day of discharge from hospital, on day 14, at 2, 6, and 12 months.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (2)

UMC Ljubljana, Department of Infectious Diseases

🇸🇮

Ljubljana, Slovenia

Department of Infectious Diseases, University Medical Center Ljubljana, Ljubljana, Slovenia

🇸🇮

Ljubljana, Slovenia

© Copyright 2025. All Rights Reserved by MedPath